Member Info for chester18

Just watch tonights programme and it was fascinating, informative, heartfelt with a very tough and sad outcome.
It brought home the work involved in setting up the trails and the emotions of the patients and their families as they deal with their individual journey.
I hope and pray that the trials we're about to see with SCIB 1 / Checkpoint Inhibitor succeed in all the patients taking part. I know that's not always possible but I'll still hold out hope.

Just shows how much a successful MODI platform is so needed..

Chester

Made up for you C7....

So glad you got such good news..
I send you all my best wishes, we just need our little bio to spark into action.....

Chester.

Looks like someone or some people are cashing in their sub 4p buys.
Consistant chunks being sold and my only thought is thier taking a chance that no news for a while means they could buy back lower. Not so sure I would be confident to do that, news could land at any time.
Good luck to them but in my honest opinion I feel its not the right time to be selling.

Chester

So the company is now only worth a little more than it paid for CellRight. Would it have gone is low without Woodford being such a large share holder, I doubt it.
So where from here, with no news or updates scheduled could the price slide even more or is this the bottom?
It would be very reassuring and helpful if the company put out a statement.

Chester

Morning Mr. O

Good info about the new jobs, it does bode well as you say, why recruit if the trial has gone pair shaped. Only a week now before the business update, you would think it has to include trial data.

I must admit I am intrigued as to the results of the second cohort, I said a month ago that the clinicians would know if the improvements in vision are similar to cohort 1.
Rene have done a solid job of keeping the news so tight, 'so far'.
The next four days trading are going to be very interesting.

Chester.

There was an announcement that the collaboration had been extended by 6 months. Which makes it very likely that there will have to be a conclusion or confirmation that it continues.
Hopefully the latter with some hints as to how the lab work is progressing.

Chester

I'm puzzled with the lack of any Biontech news. So when Vulpes stepped up and funded the next, 6 to 8 months at 5p a share it wasn't difficult to conclude that there was not going to be an up front payment Biontech deal on Modi 1 any time soon.

Now with Mondays H1 update and no mention of said Biontech what are the possible reasons.

I thought it was stated somewhere that the collaboration was to be extended by 6 months, was it said 'to the end of June'?
Or was it a further 6 months from that date in January?

Just trying to understand the 'what's and if's',
Your thoughts would be appreciated.

Chester.

What is the general view of news tomorrow?
Is it better than 50/50 because we could also hear about the Biontech collaboration?

Chester.

Going off the last one it means that there will be an RNS tomorrow but not necessarily by Scancell. But the question is still to be answered, why and who would purchase one share considering the associated costs. Therefore it would make sense if it is by an MM and it does mean something to someone. Maybe just a very rich person who likes to winding us all up..... Lol

Hi C7 When Jim Allisson said that one of the first patients (a lady) to be given the Checkpoint Inhibitor was still disease free after 18 years it brought home just how long these new platforms take to be established. The last five years of Scancell's journey has had its ups and downs. As 'just' shareholders we pay our money and sit back getting frustrated that the road is somewhat bumpy. When the reality is that it is painstakingly exacting work to be the pioneers in a new but expanding field. I am so grateful the the posters on this board who have educated those of us that wanted to listen. I'm even reading 'Molecular & Cell Biology' For Dummies, just to try and fill in the gaps. I look forward to the day I'm watching BBC 4 and their showing how LD's breakthroughs created the new era in cancer treatments. I wish everyone who reads this board the very best of health. Chester

Some new arrivals to ensure PHIII goes to plan. Going for approval full steam....

Not with standing the controversy over how much money was poured into Reneuron by Woodford and associated funds. Reneuron has actually benifitted from the freedom of financial resources and in fact freedom of having the time to get the science right. A positive update on or before the 11th July is still going to create a massive amount of publicity and strengthen all the future prospects. Woodford or not, if the science works the 'science works'... Chester..

Hi Zinzan Thank you for your swift reply. Just shows that the facts are in the details. So the financial loan is actually a dilution just the same as if achieved by a open offer. Let's hope the the SP has risen somewhat before next April. On the projected sales figures I was really surprised because TRX have seen very strong demand for their products the last 2/3 years. I can only guess it has something to do with manufacturing capacity. Chester

I have always been positive on Scancell and the ultimate destination of the science. I try to post in a fair and balanced way but I admit, I aways err towards the positive. I have been challenged by yourself and Nomlungu in the past and have always responded and explained my thinking. Not once has that explanation been acknowledged by you or Nom. In my management training I was given skills to deal with an array of situations but the most difficult type of person to deal with was someone that was 'Passive Aggressive'. Its know as a personality trait used as a control against management or authority or one peers. You do raise some valid points but you also like to gently twist the other people's words. I now read your posts through a filter that you are only here to have your fun in winding people up. You certainly don't come across as genuine shareholder and your style is always bent to the negative. As a good example, your current goading of Ratcliffewriter over a most contrived bet does you no kindness. Science gets done when it's ready, people are just people, words are like plasticine, very easily manipulated. Chester

Morning ZinzanNo8 I agree that the SP has been eroded over the last three years. My holding has an average price of 12.5p because I invested before TRX bought Cellright. That was a very positive dilution as far as I'm concerned. I also agree that the share price will hang around the 5p mark for a while, unless we hear some very positive news on new markets, new contacts or a deal. What I don't understand is why you are saying TRX will need to raise funds at 4p. They have just put in place a comprehensive loan package that will meet all outgoings well into the time where the company makes money. Also, where in all the recent news does it say that the sales targets have been reduced, I can't remember hearing that or find a document that confirms. If you could let me know where to look I would appreciate it. In the meantime the Woodford debacle is causing mayhem in the share price of many companies, it will persist for a while but it is causing a distortion in the true value of Tissue Regenix. All just my opinion and as is always said please do your own research. Chester.

Hi Casflow66 I don't exactly know why but there can be different spreads on the two platforms. Your trade must have just fallen below half way on that spread at that time. It is always happening that's why you should just follow the trend over time and not rely on the colour of any trade. MM's and their dark magic..... Chester.

Morning Casflow66 If you click on 'Home' on this page and enter RENE you will see two tickers for Reneuron. Click on the Rene.GB.Pl and that will display another platform for trades. Check trades for yesterday and your purchase may be there. Let me know if you find it OK. Chester

Good Morning Peeps, The sell off and panic of PI's has been well and truly overdone. The MM's and the Day Traders are having a feeding frenzy, but all the fundamentals are unchanged it's just the sentiment of the herd. Couldn't believe the price was still falling yesterday so had to buy just a few more so I didn't feel left out..... Lol. Serious price predictions can only be attempted either on news in the next week or so, or after the 11th July. Chester.

Hey Rene-to-40p, The only way we are all going to be disappointed in the long run is if the extraordinary results in Cohort 1 were : A) A complete fluke... I don't think so... B) The improvement plateaued after 20 weeks and has since deteriorated..... Not very likely. As soon as Rene announce a Positive Cohort 2 trial result the share price will swiftly move forward. It will also spark off more potential deals like the Fosun Pharma £80M. I know the current disaster at Woodford Inc. is unnerving but there is so much to be positive about. Anyway I've put all my spare beer tokens into Rene and I'm looking forward to the next update... Chester

So you know that I believe in what I'm saying I've just bought 4531 shares at £2.269. Chester